Literature DB >> 10570244

The structure of myristoyl-CoA:protein N-myristoyltransferase.

R S Bhatnagar1, K Fütterer, G Waksman, J I Gordon.   

Abstract

Protein N-myristoylation is a covalent modification that occurs co-translationally in eukaryotes. Myristate, a rare 14 carbon saturated fatty acid (C14:0), is attached, via an amide linkage, to the N-terminal glycine of a subset of eukaryotic and viral proteins by myristoyl-CoA:protein N-myristoyltransferase (Nmt). Genetic and biochemical studies have established that Nmt is a target for development of a new class of fungicidal drugs. The enzyme is also a potential target for development of antiviral and antineoplastic agents. The structure of Saccharomyces cerevisiae Nmt1p has been determined recently with bound substrate analogs. The Nmt fold resembles the fold of members of the GCN5-related N-acetyltransferase superfamily. The structure reveals how Nmt's myristoyl-CoA and peptide substrates are recognized and bound, and what elements control the enzyme's ordered kinetic mechanism. Acyl transfer occurs through the nucleophilic addition-elimination reaction: an oxyanion hole formed by main chain atoms polarizes the thioester carbonyl and stabilizes the transition state while deprotonation of the ammonium of the Gly acceptor appears to be mediated by Nmt's C-terminal carboxylate. The use of main chain carboxylate atoms as general base catalyst is a novel feature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570244     DOI: 10.1016/s1388-1981(99)00155-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Characterization of the self-palmitoylation activity of the transport protein particle component Bet3.

Authors:  Daniel Kümmel; Julia Walter; Martin Heck; Udo Heinemann; Michael Veit
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

2.  Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins.

Authors:  Brian T Hill; Jacek Skowronski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Effects of HIV-1 Nef on human N-myristoyltransferase 1.

Authors:  Christopher R Morgan; Brian V Miglionico; John R Engen
Journal:  Biochemistry       Date:  2011-03-30       Impact factor: 3.162

4.  Roles of N-terminal fatty acid acylations in membrane compartment partitioning: Arabidopsis h-type thioredoxins as a case study.

Authors:  José A Traverso; Chiara Micalella; Aude Martinez; Spencer C Brown; Béatrice Satiat-Jeunemaître; Thierry Meinnel; Carmela Giglione
Journal:  Plant Cell       Date:  2013-03-29       Impact factor: 11.277

5.  The rare TXNRD1_v3 ("v3") splice variant of human thioredoxin reductase 1 protein is targeted to membrane rafts by N-acylation and induces filopodia independently of its redox active site integrity.

Authors:  Marcus Cebula; Naazneen Moolla; Alexio Capovilla; Elias S J Arnér
Journal:  J Biol Chem       Date:  2013-02-14       Impact factor: 5.157

6.  Association of NMT2 with the acyl-CoA carrier ACBD6 protects the N-myristoyltransferase reaction from palmitoyl-CoA.

Authors:  Eric Soupene; Joseph Kao; Daniel H Cheng; Derek Wang; Alexander L Greninger; Giselle M Knudsen; Joseph L DeRisi; Frans A Kuypers
Journal:  J Lipid Res       Date:  2015-11-30       Impact factor: 5.922

7.  ACBD6 protein controls acyl chain availability and specificity of the N-myristoylation modification of proteins.

Authors:  Eric Soupene; Frans A Kuypers
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

8.  Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhi.

Authors:  Holger Basso; Faiza Rharbaoui; Lothar H Staendner; Eva Medina; Francisco García-Del Portillo; Carlos A Guzmán
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.

Authors:  Julie A Frearson; Stephen Brand; Stuart P McElroy; Laura A T Cleghorn; Ondrej Smid; Laste Stojanovski; Helen P Price; M Lucia S Guther; Leah S Torrie; David A Robinson; Irene Hallyburton; Chidochangu P Mpamhanga; James A Brannigan; Anthony J Wilkinson; Michael Hodgkinson; Raymond Hui; Wei Qiu; Olawale G Raimi; Daan M F van Aalten; Ruth Brenk; Ian H Gilbert; Kevin D Read; Alan H Fairlamb; Michael A J Ferguson; Deborah F Smith; Paul G Wyatt
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

10.  N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.

Authors:  James A Brannigan; Barbara A Smith; Zhiyong Yu; Andrzej M Brzozowski; Michael R Hodgkinson; Asher Maroof; Helen P Price; Franziska Meier; Robin J Leatherbarrow; Edward W Tate; Deborah F Smith; Anthony J Wilkinson
Journal:  J Mol Biol       Date:  2009-12-28       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.